Tekla Life Sciences Investors buy melinda
Start price
19.11.17
/
50%
?17.30
Target price
19.03.18
€19.39
Performance (%)
4.62%
End price
19.03.18
€18.10
Summary
This prediction ended on 19.03.18 with a price of €18.10. With a performance of 4.62%, the BUY prediction by melinda for Tekla Life Sciences Investors closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tekla Life Sciences Investors | - | - | - | - |
| iShares Core DAX® | 2.275% | 4.627% | 18.839% | 16.367% |
| iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% | 35.232% |
| iShares Nikkei 225® | 4.456% | 3.598% | 12.437% | -0.660% |
| iShares S&P 500 | 4.061% | 2.876% | 23.447% | 38.511% |
Comments by melinda for this prediction
In the thread Tekla Life Sciences Investors diskutieren
SecteurFonds Anlageinvestitionen
Tekla Life Sciences Investoren sind ein Investmentfonds mit fixem Kapital investiert in der Life Sciences Industrie. Ziel ist es , einen Mehrwert in dem langfristigen Kapitalzuwachs durch Investitionen in Life Sciences - Unternehmen zur Verfügung zu stellen.